Skip to Content
About Abbott
Contact
United States | eng
Country Language
CARDIOVASCULAR
United States | eng
Country Language

AVEIR™ VR Ventricular
Leadless Pacemakers

Advancing management of bradycardia one beat at a time

AVEIR Leadless Pacemakers
Join the leadless movement
Join Our Email List

Tailored Leadless Pacing

AVEIR VR Ventricular Leadless Pacemaker (LP) is the next evolution in leadless technology that is ideal for patients requiring single chamber pacing for bradycardia or other rhythm disorders.1 AVEIR VR LP has been designed for:

  • long-term retrieval2
  • an extended battery life
  • electrical mapping prior to fixation for optimal device location
  • providing an upgradeable platform to later support a dual chamber pacing system when patient therapy need evolves1
  • expanded procedural option with both femoral and internal jugular (IJ) access (FDA approved)
  • AVEIR VR Mini Ventricular Leadless Pacemaker provides greater implant flexibility within the right ventricle and an industry-leading projected battery life

Indications for Ventricular Single Chamber Leadless Pacing1

Ventricular Pacing for Patients with:

▪ Significant bradycardia and normal sinus rhythm with only
   rare episodes of AV block or sinus arrest

▪ Chronic atrial fibrillation

Introducing the NEW AVEIR™ VR Mini Ventricular LP

The AVEIR VR Mini Ventricular LP has:

Greater Implant Location Flexibility, with its shorter length, the AVEIR VR Mini Ventricular LP expands implant options within the right ventricle and for patients with challenging cardiac anatomies.6

Industry-Leading Projected Longevity exceeding Micra‡ VR2 and Micra‡ AV2 projected longevity by 29.4%.*,7,8

Download the flyer

*Based on published projected longevity estimates. Pacing parameters: VVI(R) pacing mode, 100% pacing, 1.5 V, 0.4 ms, 500 ohms, 60 bps. Projected longevity depends on programmed settings and patient conditions.

Designed for Long-Term Retrieval2

The AVEIR VR LP's predecessor has an overall long-term retrieval success rate of 88% with helix fixation through 9 years of retrieval experience.  Limited data is available for AVEIR VR LP.

The AVEIR VR LP's predecessor has an overall long-term retrieval success rate of 92.5% for implants ≥ 5 years.

88%
92.5%

Long Lasting

Increased projected battery longevity over current available leadless pacemakers1,4,* opens the door to more patients.

Mean ± SD: 17.6±6.6 years5
95% CI: 16.6 to 18.6 years

Projected years of battery life comparison Aveir VR leadless pacemaker vs Micra leadless pacemaker

The average battery longevity among Leadless II phase 2 IDE patients at 1 year follow-up is estimated to be 17.6 years5

48% of the study patients have an estimated battery longevity of over 20 years.5

At least
1.7x the Battery Capacity
of current ventricular  leadless pacemakers1,4,*

Aveir VR Leadless Pacemaker battery capacity 243 mAh Micra Leadless Pacemaker 120 mAh

Upgradeable System1

Patient therapy can be tailored by implanting a ventricular device alone, or both an atrial and ventricular device combined for dual chamber support. The option to upgrade over time allows you to meet your patient’s needs today and adapt to common disease progression later.


Treat rare intermittent heart block today.

AVEIR VR in heart

Add an atrial device for sick sinus syndrome later.

AVEIR DR in heart

Enable i2i™ communication.

i2i symbol

Activate dual chamber pacing therapy DDD(R) via i2i communication.

AVEIR DR in heart

Stay Informed

Sign up to hear about our technology, education opportunities, and more.

Join Our Email List

Read the Latest Blog Article

Stay up to date with recent news, product highlights, and case studies.

Visit the Abbott CRM Blog

‡ Indicates a third-party trademark, which is property of its respective owner

REFERENCES

* Battery longevity estimates based on projections derived from published technical specifications and the ISO standard settings

**For additional information about specific MR Conditional, including warnings, precautions, adverse conditions to MRI scanning and potential adverse events, please refer to the MRI-Ready Leadless Systems Manual at medical.abbott/manuals or check our MRI-Ready resources at cardiovascular.abbott/mriready

***Pacing parameters: VVI(R) pacing mode, 100% pacing, 1.5 V, 0.4 ms, 600 ohms, 60 bpm

 

  1. AVEIR Leadless Pacemakers and Delivery Catheter IFU. ARTEN600361108.
  2. Neuzil, Petr, et al. “Worldwide Chronic Retrieval Experience of Helix-Fixation Leadless Cardiac Pacemakers.” Journal of the American College of Cardiology, 2025.
  3. Knops, Reinoud E., et al. “A Dual- Chamber Leadless Pacemaker.” New England Journal of Medicine (2023). DOI: 10.1056/ NEJMoa2300080.
  4. Micra‡ VR IFU M991010A001 REV. B
  5. Reddy VY, Exner D, et al. 1-Year Outcomes of a Leadless Ventricular Pacemaker: The LEADLESS II (Phase 2) Trial. JACC : Clinical Electrophysiology 2023, DOI: 10.1016/j.jacep.2023.01.031
  6. AVEIR VR Mini Supplement doc 91183421
  7. AVEIR Leadless Pacemakers IFU. ARTEN600405131
  8. UC202307540 Micra VR2 Spec Sheet, UC202307539 Micra AV2 Spec Sheet
Manuals & Resources

Manuals & Resources

Cardiovascular Products

Cardiovascular Products

Reimbursement & Coding

Reimbursement & Coding

MAT-2608370 v15.0 | Item is approved for U.S. use only